PURE Bioscience, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2012
Total Assets: $4.5M
Liabilities Breakdown FY2012
Total Liabilities: $3.6M
Asset Breakdown
Total Assets: $4.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $877.0K | 19.7% |
| Accounts Receivable | $373.0K | 8.4% |
| Inventory | $654.0K | 14.7% |
| Property, Plant & Equipment | $257.0K | 5.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.3M | 51.5% |
Liabilities Breakdown
Total Liabilities: $3.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 53.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.7M | 46.5% |